Sociodemographic and Lifestyle Determinants of Plasma Oxidative Stress Markers 8-OHdG and F2-Isoprostanes and Associations with Metabolic Syndrome

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Black, Catherine N ^a   Bot, Mariska ^a   Scheffer, Peter G ^a   Penninx, Brenda W J H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSIS; DIGITAL STORAGE; METABOLISM; REGRESSION ANALYSIS;

CHRONIC DISEASE; HEALTH RESEARCH; METABOLIC SYNDROMES; MULTIVARIABLE REGRESSION ANALYSIS; OXIDATIVE STRESS MARKERS; PLASMA LEVELS; SAMPLE STORAGE; WEAK CORRELATION;

OXIDATIVE STRESS;

8 HYDROXYDEOXYGUANOSINE; BIOLOGICAL MARKER; COTININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOPROSTANE DERIVATIVE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; 8-OXO-7-HYDRODEOXYGUANOSINE; DEOXYGUANOSINE;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD LEVEL; CHRONIC DISEASE; FEMALE; HUMAN; LIFESTYLE; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MEASUREMENT; METABOLIC SYNDROME X; NETHERLANDS; OXIDATIVE STRESS; PHYSICAL ACTIVITY; SEX RATIO; SMOKING; SOCIOECONOMICS; ADOLESCENT; ANALOGS AND DERIVATIVES; BLOOD; CLINICAL TRIAL; DIET RESTRICTION; LONGITUDINAL STUDY; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; DEOXYGUANOSINE; FASTING; FEMALE; HUMANS; ISOPROSTANES; LIFE STYLE; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OXIDATIVE STRESS; SOCIOECONOMIC FACTORS;

EID: 84960968530     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/7530820     Document Type: Article

References (50)

1. M. M. Elahi, Y. X. Kong, and B. M. Matata, "Oxidative stress as a mediator of cardiovascular disease, " Oxidative Medicine and Cellular Longevity, vol. 2, no. 5, pp. 259-269, 2009.
2. I. Dalle-Donne, R. Rossi, R. Colombo, D. Giustarini, and A. Milzani, "Biomarkers of oxidative damage in human disease, " Clinical Chemistry, vol. 52, no. 4, pp. 601-623, 2006.
3. M. Valko, D. Leibfritz, J. Moncol, M. T. D. Cronin, M. Mazur, and J. Telser, "Free radicals and antioxidants in normal physiological functions and human disease, " International Journal of Biochemistry and Cell Biology, vol. 39, no. 1, pp. 44-84, 2007.
4. H. Kasai, H. Hayami, Z. Yamaizumi, H. Saitô, and S. Nishimura, "Detection and identification of mutagens and carcinogens as their adducts with guanosine derivatives, " Nucleic Acids Research, vol. 12, no. 4, pp. 2127-2136, 1984.
5. A. Valavanidis, T. Vlachogianni, and C. Fiotakis, "8-Hydroxy-2deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis, " Journal of Environmental Science and Health-Part C: Environmental Carcinogenesis and Ecotoxicology Reviews, vol. 27, no. 2, pp. 120-139, 2009.
6. A. Pilger and H. W. Rüdiger, "8-Hydroxy-2deoxyguanosine as a marker of oxidative DNA damage related to occupational and environmental exposures, " International Archives of Occupational and Environmental Health, vol. 80, no. 1, pp. 1-15, 2006.
7. L. J. Kroese and P. G. Scheffer, "8-Hydroxy-2deoxyguanosine and cardiovascular disease: a systematic review, " Current Atherosclerosis Reports, vol. 16, no. 11, article 452, 2014.
8. C. N. Black, M. Bot, P. G. Scheffer, P. Cuijpers, and B. W. J. H. Penninx, "Is depression associated with increased oxidative stress? A systematic review and meta-analysis, " Psychoneuroendocrinology, vol. 51, pp. 164-175, 2015.
9. E. Niki, "Biomarkers of lipid peroxidation in clinical material, " Biochimica et Biophysica Acta, vol. 1840, no. 2, pp. 809-817, 2014.
10. S. S. Davies and L. J. Roberts II, "F2-isoprostanes as an indicator and risk factor for coronary heart disease, " Free Radical Biology and Medicine, vol. 50, no. 5, pp. 559-566, 2011.
11. S. Loft, K. Vistisen, M. Ewertz, A. Tjønneland, K. Overvad, and H. E. Poulsen, "Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index, " Carcinogenesis, vol. 13, no. 12, pp. 2241-2247, 1992.
12. H. Kasai, N. Iwamoto-Tanaka, T. Miyamoto et al., "Life style and urinary 8-hydroxydeoxyguanosine, a marker of oxidative DNA damage: effects of exercise, working conditions, meat intake, body mass index, and smoking, " Japanese Journal of Cancer Research, vol. 92, no. 1, pp. 9-15, 2001.
13. T. Mizoue, S. Tokunaga, H. Kasai, K. Kawai, M. Sato, and T. Kubo, "Body mass index and oxidative DNA damage: a longitudinal study, " Cancer Science, vol. 98, no. 8, pp. 1254-1258, 2007.
14. N. Sakano, D.-H. Wang, N. Takahashi et al., "Oxidative stress biomarkers and lifestyles in Japanese healthy people, " Journal of Clinical Biochemistry and Nutrition, vol. 44, no. 2, pp. 185-195, 2009.
15. K. Tamae, K. Kawai, S. Yamasaki et al., "Effect of age, smoking and other lifestyle factors on urinary 7-methylguanine and 8-hydroxydeoxyguanosine, " Cancer Science, vol. 100, no. 4, pp. 715-721, 2009.
16. B. A. Muzembo, D. Narongpon, N. R. Ngatu, M. Eitoku, R. Hirota, and N. Suganuma, "Assessment of lifestyle effect on oxidative stress biomarkers in free-living elderly in rural Japan, " Geriatrics and Gerontology International, vol. 12, no. 3, pp. 547-554, 2012.
17. J. F. Keaney Jr., M. G. Larson, R. S. Vasan et al., "Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham study, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 3, pp. 434-439, 2003.
18. M. Irie, K. Tamae, N. Iwamoto-Tanaka, and H. Kasai, "Occupational and lifestyle factors and urinary 8-hydroxydeoxyguanosine, " Cancer Science, vol. 96, no. 9, pp. 600-606, 2005.
19. S. Basu, J. Helmersson, D. Jarosinska, G. Sällsten, B. Mazzolai, and L. Barreg?ard, "Regulatory factors of basal F2-isoprostane formation: population, age, gender and smoking habits in humans, " Free Radical Research, vol. 43, no. 1, pp. 85-91, 2009.
20. G. Block, M. Dietrich, E. P. Norkus et al., "Factors associated with oxidative stress in human populations, " American Journal of Epidemiology, vol. 156, no. 3, pp. 274-285, 2002.
21. R. A. Shanely, D. C. Nieman, D. A. Henson, F. Jin, A. M. Knab, andW. Sha, "Inflammation and oxidative stress are lower in physically fit and active adults, " Scandinavian Journal of Medicine and Science in Sports, vol. 23, no. 2, pp. 215-223, 2013.
22. S. H. Wu, X. O. Shu, W.-H. Chow et al., "Nonexercise physical activity and inflammatory and oxidative stress markers in women, " Journal of Women's Health, vol. 23, no. 2, pp. 159-167, 2014.
23. D. Il'Yasova, F. Wang, I. Spasojevic, K. Base, R. B. D'Agostino Jr., and L. E. Wagenknecht, "Urinary F2-isoprostanes, obesity, and weight gain in the IRAS cohort, " Obesity, vol. 20, no. 9, pp. 1915-1921, 2012.
24. D. Alkazemi, G. M. Egeland, L. J. Roberts II, and S. Kubow, "Isoprostanes and isofurans as non-traditional risk factors for cardiovascular disease among Canadian Inuit, " Free Radical Research, vol. 46, no. 10, pp. 1258-1266, 2012.
25. K. Fujita, H. Nishizawa, T. Funahashi, I. Shimomura, and M. Shimabukuro, "Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome, " Circulation Journal, vol. 70, no. 11, pp. 1437-1442, 2006.
26. M. Gross, M. Steffes, D. R. Jacobs Jr. et al., "Plasma F2-isoprostanes and coronary artery calcification: the CARDIA study, " Clinical Chemistry, vol. 51, no. 1, pp. 125-131, 2005.
27. M. Miyamoto, K. Kotani, S. Ishibashi, and N. Taniguchi, "The relationship between urinary 8-hydroxydeoxyguanosine and metabolic risk factors in asymptomatic subjects, " Medical Principles and Practice, vol. 20, no. 2, pp. 187-190, 2011.
28. P. Sjogren, S. Basu, M. Rosell et al., "Measures of oxidized low-density lipoprotein and oxidative stress are not related and not elevated in otherwise healthy men with the metabolic syndrome, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 12, pp. 2580-2586, 2005.
29. S. Iwanaga, N. Sakano, K. Taketa et al., "Comparison of serum ferritin and oxidative stress biomarkers between Japaneseworkers with and without metabolic syndrome, " Obesity Research and Clinical Practice, vol. 8, no. 3, pp. e271-e282, 2014.
30. J. Warolin, K. R. Coenen, J. L. Kantor et al., "The relationship of oxidative stress, adiposity and metabolic risk factors in healthy Black andWhite American youth, " Pediatric Obesity, vol. 9, no. 1, pp. 43-52, 2014.
31. B. W. J. H. Penninx, A. T. F. Beekman, J. H. Smit et al., "The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods, " International Journal of Methods in Psychiatric Research, vol. 17, no. 3, pp. 121-140, 2008.
32. C. L. Craig, A. L. Marshall, M. Sjöström et al., "International physical activity questionnaire: 12-country reliability and validity, " Medicine and Science in Sports and Exercise, vol. 35, no. 8, pp. 1381-1395, 2003.
33. World Health Organization Collaborating Centre for Drug Statistics Methodology. p. Anatomical Therapeutic Chemical (ATC) classificati, 2010.
34. S. M. Grundy, J. I. Cleeman, S. R. Daniels et al., "Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement, " Circulation, vol. 112, no. 17, pp. 2735-2752, 2005.
35. T. England, E. Beatty, A. Rehman et al., "The steady-state levels of oxidative DNA damage and of lipid peroxidation (F2-isoprostanes) are not correlated in healthy human subjects, " Free Radical Research, vol. 32, no. 4, pp. 355-362, 2000.
36. J. L. Watters, J. A. Satia, K.-A. da Costa et al., "Comparison of three oxidative stress biomarkers in a sample of healthy adults, " Biomarkers, vol. 14, no. 8, pp. 587-595, 2009.
37. K. Broedbaek, R. Ribel-Madsen, T. Henriksen et al., "Genetic and environmental influences on oxidative damage assessed in elderly Danish twins, " Free Radical Biology and Medicine, vol. 50, no. 11, pp. 1488-1491, 2011.
38. S. M. Harman, L. Liang, P. D. Tsitouras et al., "Urinary excretion of three nucleic acid oxidation adducts and isoprostane F2 measured by liquid chromatography-mass spectrometry in smokers, ex-smokers, and nonsmokers, " Free Radical Biology and Medicine, vol. 35, no. 10, pp. 1301-1309, 2003.
39. K. D. Jacob, N. Noren Hooten, A. R. Trzeciak, and M. K. Evans, "Markers of oxidant stress that are clinically relevant in aging and age-related disease, " Mechanisms of Ageing and Development, vol. 134, no. 3-4, pp. 139-157, 2013.
40. M. C. Kaya, Y. Bez, S. Selek et al., "No effect of antidepressant treatment on elevated serum ceruloplasmin level in patients with first-episode depression: a longitudinal study, " Archives of Medical Research, vol. 43, no. 4, pp. 294-297, 2012.
41. D. Janicki-Deverts, S. Cohen, K. A. Matthews, M. D. Gross, and D. R. Jacobs Jr., "Socioeconomic status, antioxidant micronutrients, and correlates of oxidative damage: the Coronary Artery Risk Development in Young Adults (CARDIA) study, " Psychosomatic Medicine, vol. 71, no. 5, pp. 541-548, 2009.
42. R. C. S. Seet, C.-Y. J. Lee, W. M. Loke et al., "Biomarkers of oxidative damage in cigarette smokers: which biomarkers might reflect acute versus chronic oxidative stress" Free Radical Biology and Medicine, vol. 50, no. 12, pp. 1787-1793, 2011.
43. S. C. Gorber, S. Schofield-Hurwitz, J. Hardt, G. Levasseur, and M. Tremblay, "The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status, " Nicotine and Tobacco Research, vol. 11, no. 1, pp. 12-24, 2009.
44. E. A. Meagher, O. P. Barry, A. Burke et al., "Alcohol-induced generation of lipid peroxidation products in humans, " The Journal ofClinical Investigation, vol. 104, no. 6, pp. 805-813, 1999.
45. A. Barden, R. R. Zilkens, K. Croft et al., "A reduction in alcohol consumption is associatedwith reduced plasma F2-isoprostanes and urinary 20-HETE excretion in men, " Free Radical Biology and Medicine, vol. 42, no. 11, pp. 1730-1735, 2007.
46. Z.-J. Zhang, "Systematic review on the association between F2-isoprostanes and cardiovascular disease, " Annals of Clinical Biochemistry, vol. 50, no. 2, pp. 108-114, 2013.
47. M. Woodward, K. D. Croft, T. A. Mori et al., "Association between both lipid and protein oxidation and the risk of fatal or non-fatal coronary heart disease in a human population, " Clinical Science, vol. 116, no. 1, pp. 53-60, 2009.
48. W. Martinet, M. W. M. Knaapen, G. R. Y. De Meyer, A. G. Herman, and M. M. Kockx, "Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques, " Circulation, vol. 106, no. 8, pp. 927-932, 2002.
49. A. Seven, S. Güzel, M. Aslan, and V. Hamuryudan, "Lipid, protein, DNA oxidation and antioxidant status in rheumatoid arthritis, " Clinical Biochemistry, vol. 41, no. 7-8, pp. 538-543, 2008.
50. S. Basu, M. Whiteman, D. L. Mattey, and B. Halliwell, "Raised levels of F2-isoprostanes and prostaglandin F2 in different rheumatic diseases, " Annals of the Rheumatic Diseases, vol. 60, no. 6, pp. 627-631, 2001.